COVID-19: Indian Vaccine COVAXIN To Launch In Market By 15 August, Says ICMR
Indian Council of Medical Research (ICMR) partnered with Bharat Biotech International (BBI) to fast-track human clinical trials of their COVID-19 vaccine.
The first made-in-India Coronavirus vaccine may be launched as early as August 15, primarily due to the fast-tracking efforts by Indian Council of Medical Research’s (ICMR) to develop ‘COVAXIN’ in partnership with Bharat Biotech International (BBI). A dozen institutes have been selected for clinical trials of the indigenous COVID-19 vaccine (BBV152 COVID vaccine), the government’s top medical research body said. The institutes have been asked by the ICMR to step up clinical trials as it is a “priority project” monitored at the top-most level of the government.
The ICMR talked about plans to launch the vaccine in the medical market for public health use by August 15, Independence Day. “It is envisaged to launch the vaccine for public health use latest by August 15, 2020, after completion of all clinical trials,” said the research body. The final outcome will depend on the co-operation of all clinical trial sites involved in this project, the ICMR told the institutes, advising them to speed up approvals related to clinical trials and ensure that subjects are enrolled.
Get more news updates on ZEE5.